Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMOND Study of daridorexant for insomnia with comorbid depression or anxiety
jRCTs031250578Active, not recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of daridorexant in Insomnia (2 cohorts), sponsored by Shionogi & Co., Ltd. Primary endpoints: Change in total ISI score in Cohort A and Change in total ISI score in Cohort B. Started Dec 2025; status: active, not recruiting.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCTs031250578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250578.